Ashkon Software



TKMR - Tekmira Pharmaceuticals Corp

TKMR Stock Chart

TKMR Profile

Tekmira Pharmaceuticals Corp logo

TKMR stock was the stock symbol for Tekmira Pharmaceuticals Corp before it changed its name to Arbutus Biopharma Corporation.

Arbutus Biopharma Corporation is a biopharmaceutical company that focuses on discovering, developing, and commercializing a cure for patients suffering from chronic hepatitis B virus (HBV) infection. The company was founded in 1992 and is headquartered in Warminster, Pennsylvania.

Arbutus Biopharma's lead product candidate, AB-729, is a subcutaneously-administered RNA interference (RNAi) therapeutic that targets HBV. The company believes that AB-729 has the potential to be a curative therapy for chronic HBV infection, which affects approximately 250 million people worldwide.

As of March 7, 2023, the market capitalization of Arbutus Biopharma Corporation was approximately $1.06 billion USD. It is important to note that investing in biopharmaceutical companies can be risky due to the nature of drug development and regulatory approval processes.


Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer